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Summary
Recent studies demonstrate that the actual interactions of polyenes with membrane
sterols are the basis for their antimycotic toxicity and not, as previously assumed, their po-
tential to form pores. Therefore, sterols must play a vital role in membranes and this func-
tion is seriously disturbed once polyenes bind to and/or sequester them. Essential mem-
brane proteins obviously require sterols for their activity. Among the various membrane
protein/ergosterol interactions discussed herein, transport proteins of the plasma mem-
brane are most likely the primary target for polyenes. All data available which support
this notion are summarized in this review. Even data obtained almost 40 years ago could
be useful in guiding future research.
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Introduction
The number of fungal infections, mainly of immu-
nocompromised patients, has greatly increased over the
past 30 years and with its high degree of mortality has
become a major health threat (1). In addition, fungi rep-
resent a serious problem for animals and plants as well
as for food security (2). Among the available antifungal
agents, the polyenes stand out for low rates of drug re-
sistance (3). In spite of their general toxicity for all eu-
karyotic cells and, consequently, the low therapeutic in-
dex, polyene antimycotics are widely used for treating
fungal infections. Their mode of action has not been
fully understood, although it has been intensely studied
and discussed for decades (4).
Numerous studies have established that polyenes spe-
cifically interact with membrane sterols, preferentially
with the fungus-specific ergosterol, and they do require
sterols for their antimycotic activity (4–7). Although apop-
tosis-like responses triggered by amphotericin B have re-
cently been suggested as possible mechanisms of toxicity
(reviewed in ref. 8), it has been widely accepted that poly-
enes kill fungal cells by permeabilizing plasma mem-
branes (PM) (4,6,8), either by forming pores (ampho-
tericin B and nystatin) or by destabilizing the membrane
(filipin). Nevertheless, doubts had been raised concern-
ing this mode of action as early as in 1974 (9–11). There-
fore, until recently a typical statement in reviews read:
'the precise way in which this fungicidal effect occurs
still remains unclear' (12). The situation has changed due
to a number of recent publications (7,13–16), which will
be summarized in the first part of this review. These
studies demonstrate that the interaction of polyenes with
membrane sterols as such is the basis for their toxicity
and the documented permeabilizing actions may only be
an additional complementary effect. In other words, ster-
ols must play a vital role in membranes, and this func-
tion is seriously disturbed once polyenes bind to and/or
sequester them. In principle, these studies suggest that a
number of essential membrane proteins, like for exam-
ple transporters, require sterols for their activity, stability
and/or regulation. In the second part of the review, we
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summarize sterol-protein interactions so far postulated
for fungal cells (17–26) and include a number of obser-
vations from the transport field (27–40); the latter may
offer guidance for future research.
Polyenes 'Primarily Kill Yeast by Simply
Binding Ergosterol'
This is the title of a last year's paper by Gray et al.
(14), except that they used 'amphotericin' instead of 'poly-
enes'. Testing natamycin, the laboratory of de Kruijff and
Breukink in Utrecht in 2008 (7) was the first that clearly
demonstrated polyene antimycotic toxicity caused by its
specific binding to ergosterol. Natamycin is a natural
product of Streptomyces natalensis and a typical polyene
of intermediate size between nystatin and amphotericin
B. Precise in vitro and in vivo studies showed that nata-
mycin binds to ergosterol, but does not form pores, not
even small ones suited for protons. Nevertheless, the
toxicity of natamycin hardly differs from that of pore-
-forming nystatin; its MIC value (minimal concentration
of inhibition) for S. cerevisiae was determined at (1.7±0.5)
mM as compared to (1.1±0.2) mM for nystatin (7).
The studies of Burke's group (13,14) were based on
the syntheses of various amphotericin B derivatives, and
their testing for ergosterol-binding and/or pore-forming
activities. The authors proved that the amino dideoxy
sugar mycosamine, typical for all mycotoxic polyenes
(Fig. 1), is essential for binding to ergosterol. They also
showed that the aglycone of natamycin does not bind
ergosterol anymore and is consequently non-toxic. Dele-
tion of the C35 hydroxy group of amphotericin B gave
rise to the compound C35deOAmB (Fig. 1), which did
not cause pore formation, was able to bind to ergosterol,
and its toxicity was only slightly reduced (14). The MIC
value was 3 as compared to 2 and 0.5 mM for natamycin
and amphotericin B, respectively. In principle, similar re-
sults were obtained with the methyl ester of 35-deoxy
amphotericin B synthesized and tested by Szpilman et
al. (16). However, the difference in the toxicity of the
deoxy compound was more than an order of magnitude
lower than that of amphotericin B; the deviation from
that of C35deOAmB was explained by the presence of
the methyl ester group (14,15).
Which and in What Way are Membrane
Proteins Affected by Interacting with Sterols?
As proven in the above studies, the main mode of
action of polyenes is their binding to ergosterol and in
this way interfering with fundamental sterol functions.
A most pertinent question therefore is which these func-
tions are. It is known that membrane sterols play a role
in a vast number of cellular reactions. Especially reac-
tions participating in endocytosis and secretion only
function efficiently in fungal cells, when the ergosterol
content of the involved membranes is not impaired (17–
21). Ergosterol is also required, for example for signal-
ling functions (22) as well as for homotypic vacuole fu-
sion (23,24), and for special types of autophagosomal re-
actions (25). Many of these physiological processes are
vital and, in principle, they all could be targets of poly-
ene antimycotics. To our knowledge, this has been tested
so far only in a vacuolar fusion assay, where indeed fili-
pin, nystatin and amphotericin B strongly inhibited
homotypic vacuolar fusion (23). This has recently been
confirmed also for natamycin (26).
Although it cannot be excluded that crucial intracel-
lular processes requiring ergosterol may be the targets
for the toxic action of polyenes, it is more likely that
polyenes preferentially interact with the sterols that are
abundant in the PM and thus are the first ones which
face and sequester the drug added to the medium. The
observation that the presence or absence of Pdr proteins,
responsible for active export of toxins, does not affect
the sensitivity towards polyenes, certainly strengthens
this assumption (André Goffeau, personal communica-
tion). This is furthermore supported by recent findings
of te Welscher et al. (15). The authors performed a trans-
criptome analysis with germinating conidia of Aspergil-
lus niger in the presence or absence of natamycin. Nata-
mycin treatment markedly increased the expression of 17
out of 20 transcripts for sugar transport proteins and 18
out of 30 for amino acid transporters; in 8 h the overall
increase of the transcripts for the two transporter groups
amounted to 6- and 2.6-fold, respectively (15). Next, they
showed that this upregulation was elicited to compen-
sate for impaired protein functions caused by the poly-
ene. The effect of natamycin was tested on several plas-
ma membrane transport systems in S. cerevisiae. Indeed,
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Fig. 1. Chemistry and biology of polyene macrolides. Molecular structures of the polyene macrolide natural products AmB, nata-
mycin, and a series of their functional group-deficient derivatives prepared via chemical synthesis (taken from ref. 14, Fig. 1A)
natamycin directly inhibited the transport of arginine,
proline and glucose (15). These data suggest that the
natamycin binding to ergosterol executes a direct effect
on transporters and consequently on the expression of
this set of vital plasma membrane proteins. On the bases
of previous independent studies (see below), te Welscher
et al. (15) propose that the same primary mechanism
holds for other polyene antimycotics.
For all that, plasma membrane transporters should
be the focus for elucidating the detailed mode of action
of polyene antimycotics. Studies describing an effect of
nystatin on membrane transport processes have appeared
since the seventies (10,11,27–29). Proton-coupled trans-
port systems for amino acids and sugars can accumulate
substrate analogues up to more than thousand fold (Ta-
ble 1 and 27–29,31,32). It was shown that their uptake
was inhibited by uncouplers like 2,4-dinitrophenol (DNP),
carbonyl cyanide-m-chlorophenylhydrazone (CCCP), or
carbonyl cyanide-p-trifluoromethoxyphenylhydrazone
(FCCP) as well as by other metabolic inhibitors. Unex-
pected and not really understood mechanistically until
today, however, was the observation that accumulated
substrate analogues were retained within the cells when
the uncouplers were added (27–29,31,32). Conversely,
the addition of nystatin caused their fast release, which
documented that substrate analogues were present in
cells in a free form. This finding was interpreted accord-
ing to the explanation prevalent at the time that poly-
enes form pores and that substrates leak out through
these pores (27–29).
Only in two instances an alternative interpretation,
namely, that the substrate efflux following the addition
of antimycotics is mediated by the transport protein, has
been tested: the sugar/proton symporter of Chlorella
HUP1 (10) and the arginine/proton symporter Can1 of
S. cerevisiae (11). Both Can1 and the heterologously ex-
pressed HUP1 protein localize in the so-called MCC
patches (Membrane Compartment of Can1), yeast plas-
ma membrane microdomains (33,34, reviewed in 35) that
are enriched in ergosterol (36 and Fig. 2). These two trans-
porters, therefore, offer ideal models to study mechanis-
tic details of polyene interference with transport activi-
ties.
Coincidentally, it was the glucose transporter HUP1
from an alga where for the first time a direct effect of
nystatin on a plasma membrane protein was postulated
(10). The HUP1 transport protein requires sterol for full
activity and when purified to homogeneity from trans-
genic yeast, the protein retains 2–3 ergosterols bound
per protein molecule (37 and Table 1). When expressed
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Fig. 2. Sites of sterol accumulation in plasma membrane coloca-
lize with MCC. Simultaneous localization of filipin-stained ster-
ols (A; red in C and D) and an MCC marker Sur7GFP (B; green
in C and D) was performed in living GYS48 cells. Wide-field
fluorescence micrographs (A–C) and the fluorescence intensity
profiles along the cell surface (D; outside the arrows in A and
B) are presented; bar: 5 mm (taken from ref. 36)
Table 1. HUP1, hexose-H+ symporter of Chlorella: heterologous expression, membrane localization, activity, properties
Expressed in Properties/Localization Reference
S. cerevisiae Active/localized in MCC patches together with ergosterol (Fig. 2) (34,36)
Lipids purified with
the protein/(mol/mol)
Ergosterol 2–3, PE 2 and PC 2 (37)
S. pombe Active/localized in terminal caps together with ergosterol (34)
E. coli Highly expressed; inactive in vivo (38)
HUP1 from E. coli
reconstituted in vesicles
Active in the presence of ergosterol (38)
Chlorella kessleri HUP1 localized in PM patches, as well as sterols stained with filipin (34, and G. Grossmann,
unpublished data)
In the presence of nystatin, HUP1 acts as facilitator; overshoot experiment
is possible (see Fig. 2)
Control + Nystatin
Accumulation of 6-dG >1000-fold 1.2-fold (10,39)
Km(influx6-dG)/mM 0.21 >10
Km(efflux6-dG)/mM 21 20
The referred studies present the following findings relevant to the topic: (i) the HUP1 protein colocalizes with sterols as shown for
S. cerevisiae, S. pombe, and Chlorella; (ii) the HUP1 transporter is inactive when expressed in bacteria lacking sterols (E. coli); (iii) in
the presence of nystatin the properties of the transporter are dramatically changed, see accumulation of 6-dG in Chlorella as well as
the Km value for influx. Abbreviations: PE=phosphatidylethanolamine, PC=phosphatidylcholine, 6-dG=6-deoxylucose
in E. coli, HUP1 is inactive except when reconstituted in
vesicles supplemented with ergosterol (37). As men-
tioned above, the non-metabolizable glucose analogue
6-deoxyglucose is accumulated over 1000-fold by HUP1
in Chlorella and is not released into the medium by treat-
ment with uncouplers or metabolic poisons; only the ad-
dition of nystatin caused the release of the analogue (10).
The classical overshoot experiment, proving the existence
of facilitator activity and refuting transport through pores
(40), clearly showed that the sterol-requiring and strictly
energy-coupled HUP1 protein was transformed to a fa-
cilitator by nystatin (Fig. 3, and ref. 10). Similar results
were obtained by in vitro experiments when Can1 activ-
ity was tested in vesicles (11). The uptake of arginine
into vesicles was driven by proton motive force gener-
ated by cytochrome c oxidase. Addition of nystatin to
vesicles containing ergosterol caused fast release of the
accumulated arginine, although a membrane potential of
–80 mV (proton and potassium gradient) was main-
tained, proving that no pores were formed. Last year, te
Welscher et al. (15) showed that natamycin inhibited
14C-arginine uptake in S. cerevisiae, but did not lead to its
efflux once accumulated. This discrepancy with the in
vitro experiment is understandable since in living cells,
rapid incorporation of arginine into proteins or its se-
questration to the vacuole proceeds. On the other hand,
there may be a difference in the mechanism between
nystatin and natamycin.
The studies carried out with the proton symporters
HUP1 and Can1 indicate that either these proteins re-
quire ergosterol for their coupling to energy or that they
convert to facilitators once their interaction with sterols
is disturbed or the sterols are replaced by polyenes. För-
ster resonance energy transfer studies in vivo showed
that in the presence of ergosterol, nystatin is located
much closer to membrane proteins than in its absence
(30). In S. cerevisiae, the hexose transporters HXT1-13 fa-
cilitate energy-independent transport of glucose but, all
the same, they are inhibited by natamycin (15). There-
fore, a mechanism different from the uncoupling of en-
ergy may have to be postulated in addition.
Conclusion
The new mode of action established for polyenes will
have two major consequences for future investigations.
First, the elucidation of the precise molecular role that
membrane sterols play while interacting with specific
membrane proteins will be greatly stimulated. Secondly,
knowledge of the actual fungal targets for toxicity as
well as the interacting group of polyenes with sterols
(14) will give rise to the possibility to improve the speci-
ficity of their interaction with ergosterol as compared to
that with cholesterol, and thus eventually help to in-
crease the therapeutic index for human patients.
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